Implementing the European Society of Cardiology 0-h/1-h algorithm in patients presenting very early after chest pain

Int J Cardiol. 2020 Dec 1:320:1-6. doi: 10.1016/j.ijcard.2020.07.037. Epub 2020 Jul 28.

Abstract

Background: The European Society of Cardiology (ESC) recommends a 0-h/1-h (0/1-h) algorithm to classify patients with suspected non-ST-segment elevation myocardial infarction (NSTEMI). However, reliable evidence about patients who present early after the onset of symptoms is limited, likely because high-sensitivity cardiac troponin (hs-cTn) values cannot increase sufficiently within that time. This study aimed to evaluate the outcomes in real-world situations that utilized the 0/1-h algorithm.

Methods: In a prospective, international, multicenter cohort study that enrolled 1638 patients presenting with acute chest pain to the emergency department, we assessed the performance of the 0/1-h algorithm using hs-cTnT and the associated 30-day rates of major adverse cardiac events: death and acute myocardial infarction (AMI).

Results: Among 1074 patients, the prevalence of AMI was 16.0%. An approximately 60.1% (n = 645) of patients visited the hospital within 3 h after onset of chest pain (less than 1 h; 18.2% [n = 196], less than 2 h; 27.5% [n = 295], and less than 3 h; 14.3% [n = 154]). Moreover, the prevalence rates of AMI were similar at all times (1 h, 16.8%; 1-2 h, 20.7%; 2-3 h, 18.2%; p = .5). According to the ESC 0/1-h algorithm, the distribution patterns of rule-out, observe, and rule-in groups were similar; however, none of the patients was diagnosed with AMI or cardiac death in the rule-out group.

Conclusion: This study revealed the applicability of the 0/1-h algorithm for the management of early presenters.

Publication types

  • Multicenter Study

MeSH terms

  • Algorithms
  • Biomarkers
  • Cardiology*
  • Chest Pain* / diagnosis
  • Chest Pain* / epidemiology
  • Cohort Studies
  • Emergency Service, Hospital
  • Humans
  • Prospective Studies
  • Troponin T

Substances

  • Biomarkers
  • Troponin T